... the first end - to - end TechBio unicorn that uses cutting - edge causal AI to unlock precision drug discovery, development and diagnostics, has unveiled an innovative drug pipeline in oncology and ...
01Net
-
23-5-2024
|
|
|
... Space Park Leicester provides state - of - the - art facilities for research, development, and ...Wire Business Wire - 23 Maggio 2024 Owkin has unveiled its pipeline of four early - stage de novo drug ...
01Net
-
23-5-2024
|
|
|
This collaboration is an important step forward for cell therapy development and manufacturing with ... 'It is crucial that we partner with companies like Portal, who are on the cutting edge of drug ...
01Net
-
21-5-2024
|
|
|
|
"Merck, a trusted leader in drug development, has been a wonderful collaborator with Dragonfly since we signed our first collaboration agreement in 2018," said Bill Haney, co - founder and CEO of ...
Adnkronos
-
21-5-2024
|
|
|
|
...//mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg View original content: https://www.prnewswire.co.uk/news - releases/biopharma - leaders - shape - the - future - of - drug - development - at ...
Adnkronos
-
21-5-2024
|
|
|
...' said RJ Tracy, senior vice president of partners, strategic development and channel at Domo. 'The ... Food and Drug Administration (FDA). Business Wire Business Wire - 21 Maggio 2024 PARIS - - (...
01Net
-
21-5-2024
|
|
|
Food and Drug Administration (FDA) for the DentalMonitoring solution to be used by orthodontists in ... This is a recognition of our 10 years of research and development in Deep Learning Artificial ...
01Net
-
21-5-2024
|
|
|
|
... DIA) annuncia di aver ricevuto l' autorizzazione 510(k) da parte della Food and Drug ... Diasorin ha collaborato con la Biomedical Advanced Research and Development Authority (BARDA), parte dell'...
FIRSTonline
-
17-5-2024
|
|
|
Serving clients worldwide for more than 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, ...
01Net
-
15-5-2024
|
|
|
... combining BenevolentAI's AI - driven drug discovery platform and biomedical knowledge with ... research funding alongside discovery, development and commercial milestones. Additionally, the Company ...
01Net
-
15-5-2024
|
|
|